SecBot SecBot
S-1/A ·Filed May 29, 2026

NUWE

Nuwellis, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed5mo ago SEC0001140361-26-023354
IPO registration amendment
Actionable Insight ▼ Bearish

This is a dilutive emergency capital raise with no minimum, meaning the company may raise far less than needed. Monitor the closing date and actual proceeds raised — if less than ~$2M, cash runway concerns intensify. Watch for any Nasdaq delisting risk if market value falls below proposed $5M threshold.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
NUWE ▼ -96.08% at T+60d
SHORT call ✓ call won +96.08% · α vs SPY +97.32% · entry $24.50 → $0.9592
Entry = T+0 close
May 29, 2026
via day close
T+1d
-15.71%
call +15.71% · α +15.85%
$20.65
settled 5mo ago
T+5d
-78.57%
call +78.57% · α +76.02%
$5.25
settled 5mo ago
T+20d
-87.55%
call +87.55% · α +86.25%
$3.05
settled 4mo ago
T+60d
-96.08%
call +96.08% · α +97.32%
$0.9592
settled 2mo ago

Executive Summary

Nuwellis, Inc. filed Amendment No. 1 to its S-1 registration statement for a best-efforts standby equity offering of up to 6,578,948 shares of common stock (or pre-funded warrants in lieu thereof), together with Series C and Series D common warrants, at an assumed combined price of $0.76 per share and accompanying warrants. The offering has no minimum and terminates June 30, 2026; net proceeds are estimated at ~$4.4M if fully subscribed. The company has a $2M market cap, a history of operating losses (net loss of $17.5M in FY2025, accumulated deficit of $316.3M), and only enough cash to fund operations through Q2 2026, making this a dilutive emergency capital raise.

Key Facts

  • Offering of up to 6,578,948 shares of common stock (or pre-funded warrants) plus Series C warrants (3x) and Series D warrants (1x) at $0.76/share combined price
  • No minimum offering amount; terminates June 30, 2026
  • Estimated net proceeds of ~$4.4M if fully sold; only ~$950K if 25% sold
  • Cash and cash equivalents of $2.083M as of March 31, 2026; cash runway only through Q2 2026
  • Net loss of $17.5M for FY2025; accumulated deficit of $316.3M
  • Two material weaknesses in internal controls over financial reporting
  • Nasdaq bid price deficiency notice received June 2025; regained compliance via reverse stock split
  • Market cap of $2M; 0% analyst bullishness (0 buy, 3 hold, 3 sell/strong sell)
  • Series D warrants have zero-cash exercise — no additional proceeds expected from them
  • Common warrants require stockholder approval to become exercisable; if not obtained, warrants have no value

Financial Impact

Up to ~$4.4M net proceeds at full subscription; dilution of ~250% of current shares outstanding (2.64M to 9.21M shares post-offering)

dilutioncashworking capital

Risk Factors

  • Offering may raise significantly less than $4.4M due to no minimum; cash runway remains critical
  • Massive dilution: shares outstanding would increase ~250% from 2.64M to 9.21M
  • Common warrants require stockholder approval to be exercisable; if not obtained, warrants have no value
  • Nasdaq delisting risk if market value falls below proposed $5M threshold or bid price falls below $1.00 again
  • Going concern risk if additional capital not raised beyond this offering

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001140361-26-023354
Document: ny20073226x2_ex10-66.htm0001140361-26-023354
Document: ny20073226x2_ex4-4.htm0001140361-26-023354
23 reports for NUWE
Performance horizon
100% Hit rate @ T+20 12 of 12 directional calls Went positive at some point 12 of 12 best @ T+60▲ +96.33%May 22, 2026
Filters
Rows
Reports for NUWE — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
8-K
NEUTRAL ★ 4/10
$0.3221awaiting T+20—$3.78 (+1073.55%)
Sep 18, 2026
5w ago
SC 13G/A
NEUTRAL ★ 3/10
$0.8700 $0.5600▼ −35.63%▼ −34.72%$3.78 (+334.48%)
Sep 17, 2026
5w ago
Press Release
BEARISH ★ 6/10
$1.09 $0.5532▲ +49.25%▲ +50.45%$3.78 (−246.79%)
Aug 27, 2026
8w ago
EFFECT
BEARISH ★ 6/10
$0.9900 $0.7915▲ +20.05%▲ +19.95%$3.78 (−281.82%)
Aug 25, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$1.01 $0.8700▼ −13.86%▼ −15.06%$3.78 (+274.26%)
Aug 13, 2026
10w ago
Press Release
BEARISH ★ 7/10
$1.30 $0.7740▲ +40.46%▲ +38.71%$3.78 (−190.77%)
Aug 3, 2026
12w ago
424B5
BEARISH ★ 7/10
$14.49 $7.13▲ +50.78%▲ +52.01%$3.78 (+73.91%)
Jul 31, 2026
12w ago
Press Release
BEARISH ★ 6/10
$1.74 $0.8889▲ +48.91%▲ +51.90%$3.78 (−117.24%)
Jun 16, 2026
19w ago
Press Release
NEUTRAL ★ 2/10
$0.1350 $0.0840▼ −37.78%▼ −37.83%$3.78 (+2700.00%)
Jun 10, 2026
19w ago
8-K
BEARISH ★ 7/10
$0.1520 $0.0869▲ +42.86%▲ +46.93%$3.78 (−2386.84%)
Showing 10 of 23

US Market Status

Market Open — Closes in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026